Valvular & structural heart diseaseResearch article
Blood biomarkers in left-sided valvular heart disease
- Narrative review
Study context
- Population
- Left-sided valvular heart disease
Main finding
As reported in the abstract
Utility of blood biomarkers in left-sided VHD
- Blood biomarkers generally not considered criteria to trigger valve intervention in the latest European and American valvular heart disease (VHD) guidelines
- Reviewed uses: presence, severity and progression of left-sided VHD; presence and extent of CV damage; prediction of outcomes before and after valve interventions; identification of patients at risk for early structural valve deterioration, valve thrombosis and paravalvular leak
Original publication
Blood biomarkers in left-sided valvular heart disease. Eur Heart J. Published 22 April 2025. doi:10.1093/eurheartj/ehaf232
Summarised from the published abstract; every number is checked against it